This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kalu I. Ogbonnaya, MD; Ridha Arem, MD
Houston, Tex

Arch Intern Med. 1991;151(12):2469-2473.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

We thank Michaels and Cameron for their interesting letters in which they made a very important distinction in the role of somatostatin and somatostatin analogues in the treatment of diabetic diarrhea as used in our article.¹ We humbly accept the correction for using somatostatin and the somatostain analogue, octreotide, interchangeably in our article.

Micheals and Cameron are correct in stating that Tsai et al² used the somatostatin analogue, octreotide, at a dose of 50 to 75 µg (not milligrams) by subcutaneous injection twice a day. We also point out an error in the dose of clonidine as quoted in our article. Clonidine is used at an average daily dose of 0.1 mg (not 1 mg). We apologize for the typographical error. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?